AI Verdict
MBOT has stronger fundamentals based on our AI analysis.
MBOT vs MBIO Fundamental Comparison
| Metric | MBOT | MBIO |
|---|---|---|
| Revenue | $2,000.0 | $0.0 |
| Net Income | $-13.1M | $-1.9M |
| Net Margin | -657,100.0% | N/A |
| ROE | -16.9% | -20.2% |
| ROA | -16.1% | -10.9% |
| Current Ratio | 23.33x | 2.22x |
| Debt/Equity | 0.03x | 1.65x |
| EPS | $-0.29 | $-0.39 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
MBOT vs MBIO: Frequently Asked Questions
Is MBOT or MBIO a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), MBOT has stronger fundamentals. MBOT is rated STRONG SELL (95% confidence) while MBIO is rated STRONG SELL (92% confidence). This is not investment advice.
How does MBOT compare to MBIO fundamentally?
Microbot Medical Inc. has ROE of -16.9% vs MUSTANG BIO, INC.'s -20.2%. Net margins are -657,100.0% vs N/A respectively.
Which stock pays higher dividends, MBOT or MBIO?
MBOT has a dividend yield of N/A or no dividend while MBIO has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in MBOT or MBIO for long term?
For long-term investing, consider that MBOT has STRONG SELL rating with 95% confidence, while MBIO has STRONG SELL rating with 92% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about MBOT vs MBIO?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For MBOT vs MBIO, the AI consensus favors MBOT based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.